Journal article
Dipeptidyl peptidase IV inhibitors as novel regulators of vascular disease
- Abstract:
-
Dipeptidyl peptidase IV (DPP-IV) has been revealed as an adipokine with potential relevance in cardiovascular disease (CVD), while clinically used DPP-IV inhibitors have demonstrated beneficial cardiovascular effects in several experimental studies. Perivascular adipose tissue (PVAT) is a unique adipose tissue depot in close anatomical proximity and bidirectional functional interaction with the vascular wall, which is a source of DPP-IV and its biology may be influenced by DPP-IV inhibition. ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Accepted manuscript, pdf, 540.6KB)
-
- Publisher copy:
- 10.1016/j.vph.2017.07.001
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
+ National Institute for Health Research
More from this funder
Funding agency for:
Antoniades, C
Grant:
NNF15CC0018486
+ British Heart Foundation
More from this funder
Funding agency for:
Antoniades, C
Grant:
NNF15CC0018486
+ NovoNordisk Foundation
More from this funder
Funding agency for:
Antoniades, C
Grant:
NNF15CC0018486
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Vascular Pharmacology Journal website
- Volume:
- 96-98
- Pages:
- 1-4
- Publication date:
- 2017-07-08
- Acceptance date:
- 2017-07-01
- DOI:
- EISSN:
-
1879-3649
- ISSN:
-
1537-1891
- Source identifiers:
-
708117
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:708117
- UUID:
-
uuid:a6b83ba7-b817-4476-a5d7-6c4652cd8c2e
- Local pid:
- pubs:708117
- Deposit date:
- 2017-07-21
Terms of use
- Copyright holder:
- Elsevier Inc
- Copyright date:
- 2017
- Notes:
- Copyright © 2017 Elsevier Inc. This is the accepted manuscript version of the article. The final version is available online from Elsevier at: https://doi.org/10.1016/j.vph.2017.07.001
If you are the owner of this record, you can report an update to it here: Report update to this record